Literature DB >> 22687963

Inflammatory bowel disease and pregnancy: overlapping pathways.

Noha Ahmed Nasef1, Lynnette R Ferguson.   

Abstract

Several studies have reported on the association between inflammatory bowel disease (IBD) and adverse pregnancy outcomes, such as preterm birth. The exact mechanisms of action are unclear; however, several pathways and processes are involved in both IBD and pregnancy that may help explain this. In this review, we discuss the immune system's T helper cells and human leukocyte antigens, inflammation, its function, and the role of Toll-like receptors (TLRs), NOD-like receptors (NLRs), and prostaglandins in the inflammatory response. For each of these topics, we consider their involvement in IBD and pregnancy, and we speculate as to how they can lead to preterm birth. Finally, we review briefly corticosteroids, biologic therapies, and immunosuppressants for the treatment of IBD, as well as their safety in use during pregnancy, with special focus on preterm birth.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22687963     DOI: 10.1016/j.trsl.2011.12.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  8 in total

1.  Surgical management of colonic perforation due to ulcerative colitis during pregnancy: Report of a case.

Authors:  Douglas Overbey; Henry Govekar; Csaba Gajdos
Journal:  World J Gastrointest Surg       Date:  2014-10-27

2.  The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.

Authors:  Vineet S Rolston; Laleh Boroujerdi; Millie D Long; Dermot P B McGovern; Wenli Chen; Christopher F Martin; Robert S Sandler; John D Carmichael; Marla Dubinsky; Gil Y Melmed
Journal:  Inflamm Bowel Dis       Date:  2018-01-18       Impact factor: 5.325

Review 3.  Emerging targets in lipid-based therapy.

Authors:  Stephanie C Tucker; Kenneth V Honn
Journal:  Biochem Pharmacol       Date:  2012-12-20       Impact factor: 5.858

Review 4.  Spontaneous preterm birth: advances toward the discovery of genetic predisposition.

Authors:  Jerome F Strauss; Roberto Romero; Nardhy Gomez-Lopez; Hannah Haymond-Thornburg; Bhavi P Modi; Maria E Teves; Laurel N Pearson; Timothy P York; Harvey A Schenkein
Journal:  Am J Obstet Gynecol       Date:  2017-12-14       Impact factor: 8.661

5.  Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease.

Authors:  Amy Yu; Sonia Friedman; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2020-11-19       Impact factor: 5.325

6.  Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.

Authors:  Heather A Boyd; Saima Basit; Maria C Harpsøe; Jan Wohlfahrt; Tine Jess
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

7.  Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.

Authors:  Uma Mahadevan; Millie D Long; Sunanda V Kane; Abhik Roy; Marla C Dubinsky; Bruce E Sands; Russell D Cohen; Christina D Chambers; William J Sandborn
Journal:  Gastroenterology       Date:  2020-11-21       Impact factor: 22.682

Review 8.  The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding.

Authors:  Katarzyna Romanowska-Próchnicka; Anna Felis-Giemza; Marzena Olesińska; Piotr Wojdasiewicz; Agnieszka Paradowska-Gorycka; Dariusz Szukiewicz
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.